Drug Chatter -- Tracking biopharma stock chatter

DrugPatentWatch - Biopharmaceutical Business Intelligence

Profile for Aldeyra Therapeutics, Inc. (ALDX)

« Back to company index

ALDX Chatter Timeline

Stock Ticker for ALDX

Most Active Tweeters for ALDX

No tweets found

Recent Tweets for ALDX

registrarjourn @registrarjourn
Aldeyra Therapeutics $ALDX Rating Reiterated by Canaccord Genuity https://t.co/z1qaencYtP
August 20th 2018, 1:08pm
EnterpriseLeade @EnterpriseLeade
Aldeyra Therapeutics $ALDX Rating Reiterated by Canaccord Genuity https://t.co/2iwM0083r9
August 20th 2018, 1:08pm
TheMarketsDaily @TheMarketsDaily
Analysts Expect Aldeyra Therapeutics, Inc $ALDX Will Post Earnings of -$0.43 Per Share https://t.co/uvaR5q95Cd
August 20th 2018, 11:08am
mmahotstuff1 @mmahotstuff1
Aldeyra Therapeutics $ALDX Stock Price Up as Sentiment Improves - https://t.co/5wnaV0oHWT
August 20th 2018, 8:08am
whatsonthorold2 @whatsonthorold2
Institutional Investors Positive on Aldeyra Therapeutics $ALDX - https://t.co/xxJ44pThCs
August 20th 2018, 8:08am
west_moreland @west_moreland
Institutional Investors Are Betting On Aldeyra Therapeutics $ALDX https://t.co/MhzblUxRtL
August 20th 2018, 8:08am
The_CasualSmart @The_CasualSmart
Institutional Investors Lead Shift in Aldeyra Therapeutics $ALDX Sentiment https://t.co/0vsZAHO0f6
August 20th 2018, 8:08am
registrarjourn @registrarjourn
Aldeyra Therapeutics $ALDX Given a $23.00 Price Target by Cantor Fitzgerald Analysts https://t.co/JJvoAjFm8M
August 19th 2018, 9:08am
MareaInformativ @MareaInformativ
Reviewing BioXcel Therapeutics $BTAI and Aldeyra Therapeutics $ALDX https://t.co/5yRAQkM6uh
August 18th 2018, 7:08pm
registrarjourn @registrarjourn
Head to Head Analysis: Aldeyra Therapeutics $ALDX versus BioXcel Therapeutics $BTAI https://t.co/iajvpzolS0
August 18th 2018, 7:08pm
ThisLincolnian @ThisLincolnian
Zacks Investment Research Downgrades Aldeyra Therapeutics $ALDX to Sell https://t.co/2RKTJPzoRX
August 18th 2018, 2:08pm
OlympiaReport @OlympiaReport
Aldeyra Therapeutics $ALDX Cut to Sell at Zacks Investment Research https://t.co/lkcORjpldo
August 17th 2018, 6:08am
WeekHerald @WeekHerald
Aldeyra Therapeutics $ALDX Cut to Sell at Zacks Investment Research https://t.co/teiMJOY3xY
August 17th 2018, 6:08am
MareaInformativ @MareaInformativ
-$0.43 EPS Expected for Aldeyra Therapeutics, Inc $ALDX This Quarter https://t.co/L2hxeoTdIr
August 17th 2018, 6:08am
dakotafinancial @dakotafinancial
-$0.43 EPS Expected for Aldeyra Therapeutics, Inc $ALDX This Quarter https://t.co/PShPQfVtcx
August 17th 2018, 6:08am
AmericanBanking @AmericanBanking
-$0.43 EPS Expected for Aldeyra Therapeutics, Inc $ALDX This Quarter https://t.co/6uozHaJqhf #stocks
August 17th 2018, 6:08am
4thQuarterCap @4thQuarterCap
Back in $ALDX
August 16th 2018, 8:08am
registrarjourn @registrarjourn
Aldeyra Therapeutics $ALDX Upgraded at Zacks Investment Research https://t.co/CaFyQY8bJg
August 16th 2018, 5:08am
EnterpriseLeade @EnterpriseLeade
Aldeyra Therapeutics $ALDX Upgraded at Zacks Investment Research https://t.co/W3Ig5czhNO
August 16th 2018, 5:08am
dispatchtribune @dispatchtribune
Aldeyra Therapeutics, Inc $ALDX Forecasted to Post FY2018 Earnings of -$1.76 Per Share https://t.co/4bdHJAbFhO
August 16th 2018, 2:08am
OlympiaReport @OlympiaReport
Aldeyra Therapeutics, Inc $ALDX Forecasted to Post FY2018 Earnings of -$1.76 Per Share https://t.co/BL5GVbPdDQ
August 16th 2018, 2:08am
registrarjourn @registrarjourn
Aldeyra Therapeutics $ALDX Lowered to “Buy” at ValuEngine https://t.co/KEMHEwXOPR
August 16th 2018, 12:08am
MareaInformativ @MareaInformativ
Aldeyra Therapeutics $ALDX Downgraded by ValuEngine to Buy https://t.co/QG8Va2EH0G
August 16th 2018, 12:08am
MareaInformativ @MareaInformativ
Aldeyra Therapeutics, Inc $ALDX Receives $22.67 Average PT from Analysts https://t.co/FflDOa4R5N
August 15th 2018, 12:08pm
TickerReport @TickerReport
Aldeyra Therapeutics $ALDX Stock Rating Lowered by Zacks Investment Research https://t.co/rOf7OYQMuh
August 15th 2018, 11:08am
WatchlistN @WatchlistN
Aldeyra Therapeutics $ALDX Lowered to Sell at Zacks Investment Research https://t.co/d2Cerpj2nT
August 15th 2018, 11:08am
TheMarketsDaily @TheMarketsDaily
FY2018 Earnings Forecast for Aldeyra Therapeutics, Inc $ALDX Issued By Cantor Fitzgerald https://t.co/k4vIqlOWoN
August 15th 2018, 8:08am
AmericanBanking @AmericanBanking
FY2018 Earnings Forecast for Aldeyra Therapeutics, Inc $ALDX Issued By Cantor Fitzgerald https://t.co/HVUQc3T92G #stocks
August 15th 2018, 8:08am
TheMarketsDaily @TheMarketsDaily
Zacks Investment Research Lowers Aldeyra Therapeutics $ALDX to Sell https://t.co/EUo10r4WRx
August 14th 2018, 5:08pm
dakotafinancial @dakotafinancial
Aldeyra Therapeutics $ALDX Given Buy Rating at Canaccord Genuity https://t.co/DlltXfoJHx
August 14th 2018, 5:08am
dispatchtribune @dispatchtribune
Aldeyra Therapeutics $ALDX Upgraded at ValuEngine https://t.co/fLazkCqJGv
August 14th 2018, 5:08am
4thQuarterCap @4thQuarterCap
Sold $ALDX +12%
August 14th 2018, 12:08am
botpicks @botpicks
Should I Go Long or Short $ALDX ?
August 13th 2018, 2:08pm
WatchlistN @WatchlistN
Aldeyra Therapeutics $ALDX Given a $23.00 Price Target by Cantor Fitzgerald Analysts https://t.co/OxOaTaPu5n
August 13th 2018, 1:08pm
TickerReport @TickerReport
Aldeyra Therapeutics $ALDX Given a $23.00 Price Target by Cantor Fitzgerald Analysts https://t.co/bBMhXJuMGV
August 13th 2018, 1:08pm
registrarjourn @registrarjourn
Aldeyra Therapeutics’ $ALDX “Buy” Rating Reiterated at Canaccord Genuity https://t.co/z1qaencYtP
August 13th 2018, 1:08pm
EnterpriseLeade @EnterpriseLeade
Aldeyra Therapeutics’ $ALDX “Buy” Rating Reiterated at Canaccord Genuity https://t.co/2iwM0083r9
August 13th 2018, 1:08pm
ConsumerFeed @ConsumerFeed
ValuEngine Upgrades Aldeyra Therapeutics $ALDX to Strong-Buy https://t.co/0jBJdsWJUw
August 13th 2018, 11:08am
TheMarketsDaily @TheMarketsDaily
Canaccord Genuity Reiterates “Buy” Rating for Aldeyra Therapeutics $ALDX https://t.co/dngaKIdypT
August 12th 2018, 2:08pm
TranscriptDaily @TranscriptDaily
Aldeyra Therapeutics $ALDX Receives “Buy” Rating from Canaccord Genuity https://t.co/Li54AoCi1a
August 12th 2018, 2:08pm
The_CasualSmart @The_CasualSmart
Estabrook Capital Management Has Decreased Norfolk Southn $NSC Holding; Aldeyra Therapeutics $ALDX Sentiment Is 3 https://t.co/Xn7Bf1bFY6
August 12th 2018, 10:08am
EnterpriseLeade @EnterpriseLeade
Cantor Fitzgerald Analysts Give Aldeyra Therapeutics $ALDX a $23.00 Price Target https://t.co/Y0W5YBp3ZH
August 12th 2018, 9:08am
MareaInformativ @MareaInformativ
Aldeyra Therapeutics $ALDX Stock Rating Upgraded by ValuEngine https://t.co/0NZ1LYyoMY
August 12th 2018, 7:08am
dakotafinancial @dakotafinancial
Aldeyra Therapeutics $ALDX Stock Rating Upgraded by ValuEngine https://t.co/zelqjWQPQ1
August 12th 2018, 5:08am
TickerReport @TickerReport
ValuEngine Upgrades Aldeyra Therapeutics $ALDX to Strong-Buy https://t.co/vD5R26Srhr
August 11th 2018, 5:08pm
WatchlistN @WatchlistN
Aldeyra Therapeutics $ALDX Upgraded to Strong-Buy at ValuEngine https://t.co/OINm8ADTUb
August 11th 2018, 5:08pm
TheMarketsDaily @TheMarketsDaily
Aldeyra Therapeutics $ALDX Issues Earnings Results, Misses Expectations By $0.03 EPS https://t.co/f3spywOnM6
August 11th 2018, 11:08am
TranscriptDaily @TranscriptDaily
Aldeyra Therapeutics $ALDX Given a $23.00 Price Target by Cantor Fitzgerald Analysts https://t.co/5ia14bzbiR
August 11th 2018, 9:08am
MareaInformativ @MareaInformativ
Aldeyra Therapeutics $ALDX PT Set at $23.00 by Cantor Fitzgerald https://t.co/wvvEgGdjYR
August 11th 2018, 9:08am
MareaInformativ @MareaInformativ
Aldeyra Therapeutics, Inc $ALDX Stake Boosted by Northern Trust Corp https://t.co/UALlx1N6Dv
August 11th 2018, 6:08am

DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC 2004 - 2018. All rights reserved.